Gold(III)-Based Anticancer Complexes

  • Author: ChemistryViews.org
  • Published: 14 April 2020
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Inorganic Chemistry/ACS Publications
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: Gold(III)-Based Anticancer Complexes

Cisplatin, a diamminedichloridoplatinum(II) complex, is an approved anticancer medication. Gold, another noble metal, might also be useful in metal-based cancer therapeutics. However, gold complexes—particularly Au(III) complexes—are vulnerable to reduction. A cyclometalated structure could lead to improved stability and help to avoid unwanted redox reactions.


Nedaossadat Mirzadeh, Suresh K. Bhargava, RMIT University, Melbourne, Australia, and colleagues have prepared a series of stable gold(III)-based complexes with cyclometalated triphenylphosphine sulfide ligands (example pictured) for anticancer applications. The team synthesized [AuCl22-2-C6H4P(S)Ph2}], [Au(κ2-S2CNEt2){κ2-2-C6H4P(S)Ph2}]PF6 (pictured), [AuCl(dppe){κC-2-C6H4P(S)Ph2}]Cl, and [Au(dppe){κ2-2-C6H4P(S)Ph2}][PF6]2 (dppe = 1,2-bis(diphenylphosphino)ethane) starting from [Bu4N][AuCl4] and Me3SnC6H4P(S)Ph2.


The team found several of the compounds are stable in solution for at least three days. Three of the complexes show cytotoxicities in vitro against five human cancer cell lines that are comparable with cisplatin. According to the researchers, the mechanism of action of the complexes involves the induction of apoptosis (programmed cell death) through the accumulation of reactive oxygen species (ROS). [Au(κ2-S2CNEt2){κ2-2-C6H4P(S)Ph2}]PF6 (pictured) also showed promising anticancer activity in mice with grafts of human cervical tumor cells.


 

 

Article Views: 1282

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


Magazine of Chemistry Europe (16 European Chemical Societies)published by Wiley-VCH